Skip to main content
Probi logo

Probi — Investor Relations & Filings

Ticker · PROB ISIN · SE0001280355 LEI · 5493004CJOCT273MU397 ST Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2008-11-26 Regulatory Filings
Country SE Sweden
Listing ST PROB

About Probi

https://www.probi.com/

Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings Classification · 1% confidence The document is a short press release (1454 characters) announcing that the company, Probi, has received a research grant (forskningsstöd) from Vinnova for a specific study. This announcement concerns funding and research activities, which relates to capital/financing or general corporate news. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). Since it announces a specific financial/funding event (receiving a grant of 1,800,000 SEK for research), it fits best under 'Capital/Financing Update' (CAP) as it directly impacts the company's financial resources for a specific project, or potentially 'Regulatory Filings' (RNS) if interpreted as a general corporate announcement. Given the specific nature of receiving funding for a project, CAP is a strong candidate. However, since it is a press release announcing a grant, which is a form of corporate news that doesn't fit the other specific financial/reporting codes, the general fallback 'Regulatory Filings' (RNS) is often used for non-standard press releases that aren't earnings or management changes. Given the options, and that this is a specific announcement about funding/support, I will classify it as RNS as it is a general regulatory/corporate announcement that doesn't fit the highly specific financial report codes, adhering to the principle that non-standard press releases often fall here unless they are clearly ER, MANG, or DIV.
2008-11-26 Swedish
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–September 2008. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business segments (Functional Food and Kosttillskott). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2008
2008-10-28 Swedish
Regulatory Filings 2008
Regulatory Filings Classification · 1% confidence The document is a press release dated 2008-10-08, announcing a commercial agreement where Probi's partner (Institut Rosell) granted exclusive rights to SALVAT to sell a probiotic supplement in Spain. It mentions the positive impact on Probi's Q4 2008 results. This is a specific business development announcement, not a comprehensive financial report (like 10-K or IR), an earnings release (ER) which usually contains key figures, or a management discussion (MDA). It is a general corporate announcement regarding a partnership and product launch. Since it doesn't fit the specific categories like M&A (TAR), Director's Dealing (DIRS), or Capital Change (CAP), the most appropriate general category for a significant business update that isn't a formal regulatory filing or earnings report is the fallback category, Regulatory Filings (RNS), as it is a public announcement of a material event.
2008-10-08 Swedish
Regulatory Filings 2008
Regulatory Filings Classification · 1% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and is dated 2008-08-26. It announces the successful outcome of a clinical study regarding a new probiotic product and its potential for future product launches in the immunity market. This type of announcement, focusing on recent operational or scientific achievements intended for immediate public dissemination, aligns best with an Earnings Release (ER) if it were quarterly results, or more generally, a Regulatory Filing (RNS) if it doesn't fit a specific financial report category. Since it is a press release detailing scientific progress and future commercial potential rather than a formal financial report (like 10-K, IR, or ER), and it is not a management change (MANG), dividend notice (DIV), or capital event (CAP), the most appropriate general category for a significant, non-standard regulatory/public announcement is RNS (Regulatory Filings/General Announcement). Given the content is a scientific/commercial update, it is not a formal financial report, nor is it an announcement *of* a report (RPA).
2008-08-26 Swedish
M&A Activity 2008
M&A Activity Classification · 1% confidence The document is explicitly titled "PRESSMEDDELANDE 2008-08-05" (Press Release) and discusses a significant investment secured by Probi's US partner, NextFoods, to support the US launch of a fruit drink. It details financing activity (securing $16 million in venture capital) related to a business operation. This falls under the category of updates on company fundraising or financing activities. While it is a press release, the core subject matter is 'Capital/Financing Update' (CAP). However, the document itself is a press release announcing news, and the final sentence states: "Pressmeddelandet från NextFoods kan läsas i sin helhet som bilaga till detta pressmeddelande." This suggests the current document is an announcement *about* another document/event. Given the content is a major financing event, CAP is the most specific content classification. If the document were purely an announcement of a report, RPA or RNS would be chosen. Since the core subject is a capital raise, CAP is the best fit, even though it is presented as a press release.
2008-08-05 Swedish
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive interim financial report for Probi for the period January–June 2008. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business segments (Functional Food, Kosttillskott). It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2008
2008-07-23 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.